Bioethical aspects of basic research and medical applications of human stem cells

被引:6
作者
Santos, Manuel J. [1 ,2 ,4 ,5 ]
Ventura-Junca, Patricio [2 ,3 ]
机构
[1] Pontificia Univ Catolica Chile, Dept Biol Celular & Mol, Fac Ciencias Biol, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Dept Pediat, Fac Med, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Ctr Bioet, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Dept Biol Celular & Mol, Fac Med, Santiago, Chile
[5] Pontificia Univ Catolica Chile, Dept Pediat, Fac Ciencias Biol, Santiago, Chile
关键词
Human Stem cells; Basic research; Bioethics; Clinical trials; translational research; BONE-MARROW-TRANSPLANTATION; CORD BLOOD BANKING; ALTERNATIVE SOURCES; ETHICAL EVALUATION; NUCLEAR TRANSFER; CLINICAL-TRIALS; GENE-THERAPY; TOURISM; EMBRYOS; GUIDELINES;
D O I
10.4067/S0716-97602012000300013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The new discoveries, the extraordinary dynamism in human stem cell (SC) research, and the great expectations of the benefits in clinical treatment of many diseases are on the edge of unparalleled advances in both: 1) the understanding of basic mechanisms of cell differentiation and development and 2) the translation from basic research to new clinical therapies. Human stem cells are obtained from different sources, such as embryo, fetal, and adult tissues, in vitro induction (iPS cells) or transdifferentiation. The evidence that these cells are pluripotent (or multipotent), meaning they have the ability to differentiate into all body tissues or tissues of the same lineage, raises the possibility that they could regenerate diseased or damaged tissue in diseases that until now have had no effective treatments. Human stem cell research and therapy raise important bioethical considerations because of the human nature of these cells and their peculiar characteristics. Here we discuss the bioethical aspects of basic human SC research and the conditions necessary for the translation of basic preclinical research into clinical use of SC.
引用
收藏
页码:317 / 326
页数:10
相关论文
共 127 条
[1]  
Agich GJ, 2001, J MED ETHICS, V27, P295
[2]  
ALVAREZ CV, 2012, J MOL ENDOCRINOL
[3]   Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient [J].
Amariglio, Ninette ;
Hirshberg, Abraham ;
Scheithauer, Bernd W. ;
Cohen, Yoram ;
Loewenthal, Ron ;
Trakhtenbrot, Luba ;
Paz, Nurit ;
Koren-Michowitz, Maya ;
Waldman, Dalia ;
Leider-Trejo, Leonor ;
Toren, Amos ;
Constantini, Shlomi ;
Rechavi, Gideon .
PLOS MEDICINE, 2009, 6 (02) :221-231
[4]   Regenerative medicine: a 2009 overview [J].
Andersson, E. R. ;
Lendahl, U. .
JOURNAL OF INTERNAL MEDICINE, 2009, 266 (04) :303-310
[5]   Stem-cell laws in China fall short [J].
不详 .
NATURE, 2010, 467 (7316) :633-633
[6]  
[Anonymous], 2005, ALT SOURC HUM PLUR S
[7]   Amniotic Fluid Stem Cells: a Promising Therapeutic Resource for Cell-Based Regenerative Therapy [J].
Antonucci, Ivana ;
Pantalone, Andrea ;
Tete, Stefano ;
Salini, Vincenzo ;
Borlongan, Cesar V. ;
Hess, David ;
Stuppia, Liborio .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (13) :1846-1863
[8]  
AUDLEY D, 2011, OPEN LETT
[9]  
Austriaco Nicanor Pier Giorgio, 2006, Natl Cathol Bioeth Q, V6, P517
[10]   Patenting human pluripotent cells: balancing commercial, academic and ethical interests [J].
Bahadur, G. ;
Morrison, M. .
HUMAN REPRODUCTION, 2010, 25 (01) :14-21